Shares of Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report) hit a new 52-week low during trading on Monday . The company traded as low as C$0.01 and last traded at C$0.01, with a volume of 45000 shares. The stock had previously closed at C$0.01.
Aequus Pharmaceuticals Stock Down 50.0 %
The company’s fifty day simple moving average is C$0.01 and its 200 day simple moving average is C$0.02. The firm has a market capitalization of C$663,150.00, a P/E ratio of -0.50 and a beta of -0.02. The company has a current ratio of 0.07, a quick ratio of 0.46 and a debt-to-equity ratio of 138.88.
Aequus Pharmaceuticals Company Profile
Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease.
Recommended Stories
- Five stocks we like better than Aequus Pharmaceuticals
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Golden Cross Stocks: Pattern, Examples and Charts
- 2 Drone Stocks Surging from Increased Media Attention
- 5 discounted opportunities for dividend growth investors
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Aequus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aequus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
